Form 4: United Therapeutics Director Christopher Causey Executes Stock Option and Sells Shares
SEC Form 4
Director Christopher Causey exercised stock options and sold 2,000 shares of United Therapeutics Corp (UTHR) on May 15, 2024.
Summary
- On May 15, 2024, Christopher Causey, a director of United Therapeutics Corporation, executed stock options to acquire 2,000 shares of common stock at a price of $112.14 per share.
- Simultaneously, Causey sold 2,000 shares of common stock at a price of $272.9 per share.
- Following these transactions, Causey directly owns 4,185 shares of United Therapeutics Corporation.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions, with no inherent positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the trading activities of company directors.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the director's stock activity.
Key Dates
| Date | Description |
|---|---|
| 06/26/2019 | Date stock options were exercisable |
| 06/26/2028 | Expiration date of stock options |
| 05/15/2024 | Date of stock option exercise and share sale |
| 05/16/2024 | Date of Power of Attorney signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.